Community Coalitions' Perspectives on Engaging with Hospitals in Ohio to Address the Opioid Crisis

Daniel M Walker, Karen Shiu-Yee, Sadie Chen, Matthew J DePuccio, Rebecca D Jackson, Ann Scheck McAlearney, Daniel M Walker, Karen Shiu-Yee, Sadie Chen, Matthew J DePuccio, Rebecca D Jackson, Ann Scheck McAlearney

Abstract

Community coalitions have been leading the multisector response to the opioid epidemic in the Unites States. However, with the medicalization of opioid use disorder and changing health care policies, hospitals have moved to the forefront, becoming more active in collaborating with community coalitions. Little is currently known about how community coalitions view and approach collaborating with hospitals despite its importance for understanding and advancing interorganizational approaches to combating the opioid epidemic. Using data from semistructured interviews (n = 119) conducted from November 2019 to January 2020 as part of the HEALing Communities Study (ClinicalTrials.gov: NCT04111939), the authors examined how community coalition members perceive hospital collaborations and explored the opportunities and challenges of these partnerships. They characterized 3 emergent themes: coalition approaches to collaborating with hospitals, barriers to collaboration, and opportunities for sustainable relationships. This new evidence highlights the value that coalitions place on hospital collaborations, as well as mechanisms that may help support ongoing partnerships.

Keywords: coalitions; community benefits; hospitals; opioids.

Conflict of interest statement

The authors declare that there is no conflict of interest.

References

    1. Centers for Disease Control and Prevention. Drug Overdose Death in the U.S. Top 100,000 Annually. National Center for Health Statistics; 2021. Accessed January 4, 2022.
    1. Mattson CL, Tanz LJ, Quinn K, Kariisa M, Patel P, Davis NL. Trends and geographic patterns in drug and synthetic opioid overdose deaths—United States, 2013–2019. MMWR Morb Mortal Wkly Rep 2021;70:202–207.
    1. Florence C, Luo F, Rice K. The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017. Drug Alcohol Depend 2021;218:108350.
    1. Florence C, Luo F, Xu L, Zhou C. The economic burden of prescription opioid overdose, abuse and dependence in the United States, 2013. Med Care 2016;54:901–906.
    1. Franz B, Skinner D, Kelleher K. Why don't hospitals prioritize substance abuse in their community benefit programming? J Public Health Manage Pract 2019;25:62–68.
    1. Butterfoss FD, Kegler MC. A coalition model for community action. In: Minkler M, ed. Community organizing for community building for health and welfare. 3rd ed. New Brunswick, NJ: Rutgers University Press; 2012:21.
    1. Butterfoss FD, Goodman RM, Wandersman A. Community coalitions for prevention and health promotion. Health Educ Res 1993;8:315–330.
    1. Savic M, Best D, Manning V, Lubman DI. Strategies to facilitate integrated care for people with alcohol and other drug problems: a systematic review. Subst Abuse Treat Prev Policy 2017;12:19.
    1. Koh HK, Bantham A, Geller AC, et al. . Anchor institutions: best practices to address social needs and social determinants of health. Am J Public Health 2020;110:309–316.
    1. National Institute on Drug Abuse. Drugs, Brains, and Behavior: The Science of Addiction. U.S. Department of Health and Human Services; 2020. Accessed January 4, 2022.
    1. Volkow ND, Koob GF, McLellan AT. Neurobiologic advances from the brain disease model of addiction. Longo DL, ed. N Engl J Med 2016;374:363–371.
    1. Skinner D, Gardner W, Kelleher KJ. When hospitals join the community: practical considerations and ethical frameworks. J Health Care Poor Underserved 2016;27:1171–1182.
    1. Rozier MD. Nonprofit hospital community benefit in the U.S.: a scoping review from 2010 to 2019. Front Public Health 2020;8:72.
    1. Hilts KE, Yeager VA, Gibson PJ, Halverson PK, Blackburn J, Menachemi N. Hospital partnerships for population health: a systematic review of the literature. J Healthc Manag 2021;66:170–198.
    1. Walsh SL, El-Bassel N, Jackson RD, et al. . The HEALing (Helping to End Addiction Long-term SM) Communities Study: protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices. Drug Alcohol Depend 2020;217:108335.
    1. Knudsen HK, Drainoni ML, Gilbert L, et al. . Model and approach for assessing implementation context and fidelity in the HEALing Communities Study. Drug Alcohol Depend 2020;217:108330.
    1. Sprague Martinez L, Rapkin BD, Young A, et al. . Community engagement to implement evidence-based practices in the HEALing communities study. Drug Alcohol Depend 2020;217:108326.
    1. Drainoni ML, Knudsen HK, Adams K, et al. . Community coalition and key stakeholder perceptions of the community opioid epidemic before an intensive community-level intervention. J Subst Abuse Treat 2022;138:108731.
    1. Glasgow RE, Harden SM, Gaglio B, et al. . RE-AIM planning and evaluation framework: adapting to new science and practice with a 20-year review. Front Public Health 2019;7:64.
    1. Skjott Linneberg M, Korsgaard S. Coding qualitative data: a synthesis guiding the novice. QRJ 2019;19:259–270.
    1. Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res 2005;15:1277–1288.
    1. Bowen GA. Naturalistic inquiry and the saturation concept: a research note. Qual Res 2008;8:137–152.
    1. White DE, Oelke ND, Friesen S. Management of a large qualitative data set: establishing trustworthiness of the data. Int J Qual Methods 2012;11:244–258.
    1. Alberti PM, Sutton KM, Baker M. Changes in teaching hospitals' community benefit spending after implementation of the Affordable Care Act. Acad Med 2018;93:1524–1530.
    1. Ferdinand AO, Epane´ JP, Menachemi N. Community benefits provided by religious, other nonprofit, and for-profit hospitals: a longitudinal analysis 2000–2009. Health Care Manage Rev 2014;39:145–153.
    1. Tilgner S, Himes L, Allan T, Wasowski K, Bickford B, Burden W. Ohio Statewide efforts to align public health/health care population health planning. J Public Health Manage Pract 2018;24:S66–S68.
    1. Cronin CE, Franz B, Gran BK. Hospital community benefit in rural appalachia: one more gap. Rural Sociol 2021;86:5–25.
    1. Cronin CE, Franz B, Pagán JA. Why are some US nonprofit hospitals not addressing opioid misuse in their communities? Popul Health Manage 2020;23:407–413.
    1. Walker DM, Mora AM, Hogan TH, Diana ML, McAlearney AS. Assessing trends in hospital system structures from 2008 to 2015. Med Care 2018;56:831–839.
    1. Joseph JJ, Glover A, Olayiwola JN, et al. . Mask up: academic-community-government partnerships to advance public health during COVID-19. Popul Health Manage 2021;24:430–432.
    1. Hartley DM, Beck AF, Seid M, et al. . Multi-sector situational awareness in the COVID-19 pandemic: the Southwest Ohio experience. In: Berube DM, ed. Pandemic communication and resilience. Risk, systems and decisions. Cham, Switzerland: Springer International Publishing; 2021:265–278.
    1. Cronin CE, Franz B, Choyke K, Rodriguez V, Gran BK. For-profit hospitals have a unique opportunity to serve as anchor institutions in the U.S. Prev Med Rep 2021;22:101372.
    1. Masson CL, Sorensen JL, Perlman DC, et al. . Hospital- versus community–based syringe exchange: a randomized controlled trial. AIDS Educ Prev 2007;19:97–110.
    1. Miele GM, Caton L, Freese TE, et al. . Implementation of the hub and spoke model for opioid use disorders in California: rationale, design and anticipated impact. J Subst Abuse Treat 2020;108:20–25.
    1. Cronin CE, Franz B, Skinner D, Haile ZT. Hospitals and substance use disorder services in the time of the opioid epidemic. Health Serv Res 2019;54:399–406.
    1. Christens BD, Butterfoss FD, Minkler M, Wolff T, Francisco VT, Kegler MC. Learning from coalitions' efforts to promote equity and justice. Health Educ Behav 2019;46(1_suppl):110S–114S.
    1. Sharfstein JM, Olsen Y. How not to spend an opioid settlement. JAMA 2020;323:1031.
    1. Langford DJ, Gross JB, Doorenbos AZ, Tauben DJ, Loeser JD, Gordon DB. Evaluation of the impact of an online opioid education program for acute pain management. Pain Med 2020;21:55–60.
    1. Rutkow L, Smith KC, Lai AY, Vernick JS, Davis CS, Alexander GC. Prescription drug monitoring program design and function: a qualitative analysis. Drug Alcohol Depend 2017;180:395–400.
    1. Lefebvre RC, Chandler RK, Helme DW, et al. . Health communication campaigns to drive demand for evidence-based practices and reduce stigma in the HEALing communities study. Drug Alcohol Depend 2020;217:108338.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi